Skip to main content
. 2014 Oct 1;31(10):1045–1058. doi: 10.1007/s12325-014-0156-2

Table 2.

Subject characteristics

Variable Treatment (left eye/right eye) All subjects
Olopatadine/epinastine Epinastine/olopatadine
n 25 25 50
Sex, n (%)
 Male 14 (56.0) 14 (56.0) 28 (56.0)
 Female 11 (44.0) 11 (44.0) 22 (44.0)
Age, years
 Mean ± SD 33.1 ± 9.5 33.5 ± 9.1 33.3 ± 9.2
 Range 20–49 21–53 20–53

SD standard deviation